If you need more lookups,
subscriptions start at $34 USD/month.
Dolly Thomas Location
Boston, MA, US
Dolly Thomas Work
Hematopoietic Stem Cell Process Development @ (April 2023 - Present)
Principal Scientist @ (March 2022 - October 2023)
Senior Scientist @ (July 2020 - March 2022)
Scientist @ (November 2017 - July 2020)
Postdoctoral Research Fellow @ (January 2015 - November 2017)
PHD @ (August 2008 - January 2014)
PhD Student @ (January 2008 - January 2014)
Research Assistant @ Mount Sinai School of Medicine (January 2006 - January 2008)
Internship @ (January 2005 - January 2006)
Dolly Thomas Education
Boston University School of Medicine
Doctor of Philosophy (PhD) (Cell and Mole)
New Jersey Institute of Technology
Bachelor of Science (B.S.) (Bioengineering and Biomedical Engineering)
Dolly Thomas Skills
Cell Biology
Cell Culture
Cell Line Development
Culture of human and mouse hematopoietic stem progenitor cells
Directed differentiation of human and mouse HSPC and pluripotent stem cells
Flow Cytometry
Fluorescence Microscopy
Hematopoiesis
Immunohistochemistry
In vitro hematopoietic assays
In vivo studies (for PK/PD/Tox)
Lentivirus
Life Sciences
Microscopy
Molecular Biology
Molecular Cloning
PCR
Science
Stem Cell Research
Transduction of mouse and human hematopoietic cells
Western Blotting
qPCR
Dolly Thomas Summary
Dolly Thomas, based in Boston, MA, US, is currently a Hematopoietic Stem Cell Process Development at bluebird bio. Dolly Thomas brings experience from previous roles at Rubius Therapeutics and Dana-Farber Cancer Institute / Harvard Medical School. Dolly Thomas holds a Doctor of Philosophy (PhD) in Cell and Mole @ Boston University School of Medicine. With a robust skill set that includes Cell Biology, Cell Culture, Cell Line Development, Culture of human and mouse hematopoietic stem progenitor cells, Directed differentiation of human and mouse HSPC and pluripotent stem cells and more. Dolly Thomas has 1 mobile phone numbers on RocketReach.
Looking for a different Dolly Thomas?
Find contact details for 700 million professionals.